Cormorant Asset Management’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2.26M Buy
2025
Q1
Sell
2024
Q4
$4.67M Hold
2024
Q3
$2.62M Hold
2024
Q2
$2.75M Hold
2024
Q1
$4.28M Hold
2023
Q4
$3.25M Buy
2018
Q2
Sell
2018
Q1
$12.7M Buy